Cepheid Swot Analysis

Executive summary

Cepheid (NASDAQ: CPHD) is a leading nucleic acid (NA) testing company based in Sunnyvale, CA. Founded in 1996, the company develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets.

 

 

Table of content

Abstract

Highlights

Introduction
   Context

SWOT Analysis
   Strengths
   Weaknesses
   Opportunities
   Threats

Appendix
   Cepheid R&D pipeline
   Partnership model
   Cepheid intellectual propriety
   MDx platforms
   Table of exhibits
   Abbreviations

Disclosure

Table of exhibits:

Exhibit 1: Qiagen SWOT analysis
Exhibit 2: Cepheid's projected U.S. menu
Exhibit 3: Tradeoffs of the partnership model
Exhibit 4: Selected MDx platforms

 

 

Publication date: Number of pages: Price:
2010-02-03 16 350 euros